OncoCyte Corp
NASDAQ:OCX
OncoCyte Corp
NASDAQ:OCX
Kurs:
3,16
USD
-1,25%
Markt geschlossen
Marktkap.:
$90,38 Mio.
Notiz hinzufügen
Kursziel hinzufügen
Gedanken festhalten und ein Kursziel setzen
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Basierend auf
Sicherheitsmarge
0%
10%
20%
30%
40%
50%
Ihr Kursziel
Verknüpft mit
aktuellem Kurs
· In Kaufzone
Lädt
Notiz verknüpft
Wählen Sie die Aktie, die Sie mit einem Kursziel beobachten möchten
Zuletzt angesehen
|
OncoCyte Corp
NASDAQ:OCX
|
US |
Gewinn- und Verlustrechnung
Ergebnis-Wasserfall
OncoCyte Corp
OncoCyte Corp
Gewinn- und Verlustrechnung
OncoCyte Corp
OncoCyte Corp
Währung: USD
| Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatz | |||||||||||||||||||||||||||||||||||||||||
| Zinsaufwand |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Umsatz |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+700%
|
1
+350%
|
1
+69%
|
2
+90%
|
4
+81%
|
5
+10%
|
2
-52%
|
1
-34%
|
(0)
N/A
|
(1)
-268%
|
1
N/A
|
1
-8%
|
1
+25%
|
1
+33%
|
2
+3%
|
1
-8%
|
1
-26%
|
1
-31%
|
2
+165%
|
4
+104%
|
|
| Bruttogewinn | |||||||||||||||||||||||||||||||||||||||||
| Umsatzkosten |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(3)
|
(5)
|
(6)
|
(1)
|
0
|
2
|
4
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
| Bruttogewinn |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-138%
|
(0)
-13%
|
(1)
-49%
|
(0)
+38%
|
(1)
-43%
|
(1)
-144%
|
1
N/A
|
2
+12%
|
2
+26%
|
3
+30%
|
(0)
N/A
|
(0)
-1.200%
|
(0)
+92%
|
1
N/A
|
0
-17%
|
0
-26%
|
0
-72%
|
(0)
N/A
|
1
N/A
|
2
+173%
|
|
| Operatives Ergebnis | |||||||||||||||||||||||||||||||||||||||||
| Operative Kosten |
(5)
|
(7)
|
(9)
|
(10)
|
(11)
|
(12)
|
(11)
|
(13)
|
(14)
|
(18)
|
(19)
|
(18)
|
(19)
|
(15)
|
(15)
|
(15)
|
(17)
|
(19)
|
(22)
|
(27)
|
(29)
|
(30)
|
(29)
|
(32)
|
(37)
|
(43)
|
(53)
|
(47)
|
(33)
|
(21)
|
2
|
18
|
9
|
5
|
(17)
|
(38)
|
(37)
|
(43)
|
(20)
|
(19)
|
|
| Vertriebs-, Verwaltungs- und Gemeinkosten |
(1)
|
(2)
|
(4)
|
(5)
|
(6)
|
(6)
|
(5)
|
(7)
|
(7)
|
(11)
|
(12)
|
(11)
|
(12)
|
(8)
|
(9)
|
(9)
|
(11)
|
(13)
|
(15)
|
(19)
|
(20)
|
(23)
|
(23)
|
(24)
|
(29)
|
(31)
|
(20)
|
(22)
|
(14)
|
(12)
|
(22)
|
(20)
|
(20)
|
(18)
|
(14)
|
(13)
|
(12)
|
(13)
|
(14)
|
(15)
|
|
| F&E |
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(9)
|
(11)
|
(10)
|
(11)
|
(5)
|
(4)
|
(3)
|
(2)
|
(7)
|
(7)
|
(6)
|
(7)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
|
| Abschreibungen |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Sonstige operative Kosten |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
3
|
3
|
(1)
|
(27)
|
(22)
|
(15)
|
(8)
|
31
|
45
|
37
|
31
|
6
|
(16)
|
(13)
|
(21)
|
4
|
7
|
|
| Operatives Ergebnis |
(5)
N/A
|
(7)
-26%
|
(9)
-30%
|
(10)
-18%
|
(11)
-11%
|
(12)
-1%
|
(11)
+4%
|
(13)
-14%
|
(14)
-8%
|
(18)
-31%
|
(19)
-4%
|
(18)
+3%
|
(19)
-4%
|
(15)
+20%
|
(15)
-1%
|
(15)
-1%
|
(17)
-8%
|
(19)
-14%
|
(22)
-18%
|
(27)
-21%
|
(30)
-10%
|
(31)
-3%
|
(29)
+4%
|
(33)
-11%
|
(37)
-15%
|
(45)
-20%
|
(51)
-14%
|
(45)
+11%
|
(31)
+31%
|
(19)
+40%
|
2
N/A
|
17
+689%
|
9
-48%
|
5
-40%
|
(17)
N/A
|
(38)
-128%
|
(37)
+3%
|
(44)
-19%
|
(19)
+56%
|
(17)
+12%
|
|
| Vorsteuergewinn | |||||||||||||||||||||||||||||||||||||||||
| Zinserträge/-aufwendungen |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Nicht wiederkehrende Posten |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(1)
|
(1)
|
(0)
|
0
|
1
|
1
|
(1)
|
1
|
(2)
|
(3)
|
(20)
|
(26)
|
(25)
|
(26)
|
(9)
|
(3)
|
0
|
0
|
(42)
|
(42)
|
|
| Sonstige Erträge gesamt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Vorsteuergewinn |
(5)
N/A
|
(7)
-26%
|
(9)
-30%
|
(10)
-18%
|
(11)
-11%
|
(12)
-2%
|
(11)
+4%
|
(13)
-16%
|
(14)
-10%
|
(19)
-30%
|
(19)
-5%
|
(18)
+5%
|
(19)
-4%
|
(15)
+21%
|
(16)
-3%
|
(16)
-1%
|
(17)
-5%
|
(19)
-14%
|
(22)
-18%
|
(27)
-22%
|
(31)
-14%
|
(33)
-5%
|
(31)
+5%
|
(34)
-8%
|
(37)
-9%
|
(44)
-19%
|
(53)
-20%
|
(45)
+15%
|
(34)
+24%
|
(22)
+35%
|
(19)
+15%
|
(9)
+50%
|
(16)
-75%
|
(21)
-29%
|
(25)
-19%
|
(40)
-61%
|
(36)
+10%
|
(43)
-19%
|
(61)
-41%
|
(58)
+4%
|
|
| Nettogewinn | |||||||||||||||||||||||||||||||||||||||||
| Steueraufwand |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
8
|
10
|
10
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Ergebnis aus fortgeführten Geschäftsbereichen |
(5)
|
(7)
|
(9)
|
(10)
|
(11)
|
(12)
|
(11)
|
(13)
|
(14)
|
(19)
|
(19)
|
(18)
|
(19)
|
(15)
|
(16)
|
(16)
|
(17)
|
(19)
|
(22)
|
(26)
|
(30)
|
(32)
|
(30)
|
(26)
|
(28)
|
(35)
|
(44)
|
(43)
|
(34)
|
(22)
|
(19)
|
(9)
|
(16)
|
(21)
|
(25)
|
(40)
|
(36)
|
(43)
|
(61)
|
(58)
|
|
| Nettogewinn |
(5)
N/A
|
(7)
-26%
|
(9)
-30%
|
(10)
-18%
|
(11)
-11%
|
(12)
-2%
|
(11)
+4%
|
(13)
-16%
|
(14)
-10%
|
(19)
-30%
|
(19)
-5%
|
(18)
+5%
|
(19)
-4%
|
(15)
+21%
|
(16)
-3%
|
(16)
-1%
|
(17)
-5%
|
(19)
-14%
|
(22)
-18%
|
(26)
-17%
|
(30)
-14%
|
(32)
-5%
|
(30)
+5%
|
(26)
+13%
|
(28)
-5%
|
(35)
-26%
|
(64)
-86%
|
(70)
-10%
|
(68)
+3%
|
(64)
+6%
|
(73)
-15%
|
(60)
+18%
|
(61)
-1%
|
(58)
+5%
|
(29)
+50%
|
(41)
-42%
|
(37)
+10%
|
(44)
-18%
|
(61)
-40%
|
(58)
+4%
|
|
| Verwässertes EPS |
-5,03
N/A
|
-5,28
-5%
|
-8,32
-58%
|
-8,11
+3%
|
-9
-11%
|
-8,72
+3%
|
-8,39
+4%
|
-8,92
-6%
|
-9,65
-8%
|
-11,94
-24%
|
-12,83
-7%
|
-11,67
+9%
|
-9,87
+15%
|
-7,57
+23%
|
-8,32
-10%
|
-6,79
+18%
|
-6,42
+5%
|
-7,29
-14%
|
-8,76
-20%
|
-8,56
+2%
|
-9,12
-7%
|
-9,39
-3%
|
-9,14
+3%
|
-6,35
+31%
|
-6,12
+4%
|
-7,55
-23%
|
-14,4
-91%
|
-15,28
-6%
|
-10,05
+34%
|
-10,81
-8%
|
-13,25
-23%
|
-7,98
+40%
|
-7,49
+6%
|
-6,98
+7%
|
-3,75
+46%
|
-4,94
-32%
|
-2,85
+42%
|
-3,17
-11%
|
-4,66
-47%
|
-2,26
+52%
|
|
Wechseln zu:
Wechseln zu:
Auch interessant
Other OncoCyte Corp listings:
Mehr entdecken
